Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Brent R. Logan PhD

Brent R. Logan PhD profile photo picture

Director, Professor

Institution: Medical College of Wisconsin
Department: Institute for Health and Equity
Division: Biostatistics
Program: Research

Director of the Institute for Health & Equity
Member of the Cancer Center

View Curriculum Vitae

Research Experience

  • Multiple Comparison Procedures

    • Publications (236)

  • Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium study. (Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, Mallhi K, Chellapandian D, Lim SS, Deal CL, Kapoor N, Murguía-Favela L, Falcone EL, Prasad VK, Touzot F, Bleesing JJ, Chandrakasan S, Heimall JR, Bednarski JJ, Broglie LA, Chong HJ, Kapadia M, Prockop S, Dávila Saldaña BJ, Schaefer E, Bauchat AL, Teira P, Chandra S, Parta M, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Malech HL, Kang EM, Leiding JW) J Allergy Clin Immunol 2024 May;153(5):1423-1431.e2 PMID: 38290608 PMCID: PMC11070290 SCOPUS ID: 2-s2.0-85185611997 01/31/2024    
  • Statistical rules for safety monitoring in clinical trials. (Martens MJ, Logan BR) Clin Trials 2024 Apr;21(2):152-161 PMID: 37877375 PMCID: PMC11003847 SCOPUS ID: 2-s2.0-85174803819 10/25/2023    
  • Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study. (Eissa H, Thakar MS, Shah AJ, Logan BR, Griffith LM, Dong H, Parrott RE, O'Reilly RJ, Dara J, Kapoor N, Forbes Satter L, Chandra S, Kapadia M, Chandrakasan S, Knutsen A, Jyonouchi SC, Molinari L, Rayes A, Ebens CL, Teira P, Dávila Saldaña BJ, Burroughs LM, Chaudhury S, Chellapandian D, Gillio AP, Goldman F, Malech HL, DeSantes K, Cuvelier GDE, Rozmus J, Quinones R, Yu LC, Broglie L, Aquino V, Shereck E, Moore TB, Vander Lugt MT, Mousallem TI, Oved JH, Dorsey M, Abdel-Azim H, Martinez C, Bleesing JH, Prockop S, Kohn DB, Bednarski JJ, Leiding J, Marsh RA, Torgerson T, Notarangelo LD, Pai SY, Pulsipher MA, Puck JM, Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Heimall J) J Allergy Clin Immunol 2024 Jan;153(1):287-296 PMID: 37793572 SCOPUS ID: 2-s2.0-85176234805 10/05/2023    
  • Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease. (Chandrasekaran P, Han Y, Zerbe CS, Heller T, DeRavin SS, Kreuzberg SA, Marciano BE, Siu Y, Jones DR, Abraham RS, Stephens MC, Tsou AM, Snapper S, Conlan S, Subramanian P, Quinones M, Grou C, Calderon V, Deming C, Leiding JW, Arnold DE, Logan BR, Griffith LM, Petrovic A, Mousallem TI, Kapoor N, Heimall JR, Barnum JL, Kapadia M, Wright N, Rayes A, Chandra S, Broglie LA, Chellapandian D, Deal CL, Grunebaum E, Lim SS, Mallhi K, Marsh RA, Murguia-Favela L, Parikh S, Touzot F, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Kang EM, Malech HL, Segre JA, Bryant CE, Holland SM, Falcone EL) J Allergy Clin Immunol 2023 Dec;152(6):1619-1633.e11 PMID: 37659505 SCOPUS ID: 2-s2.0-85176115441 09/03/2023       2 Citations
  • Dynamic Treatment Regimes Using Bayesian Additive Regression Trees for Censored Outcomes. (Li X, Logan BR, Hossain SMF, Moodie EEM) Lifetime Data Anal 2024 Jan;30(1):181-212 PMID: 37659991 PMCID: PMC10764602 SCOPUS ID: 2-s2.0-85169623013 09/03/2023    
  • Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study. (Versluis J, Saber W, Tsai HK, Gibson CJ, Dillon LW, Mishra A, McGuirk J, Maziarz RT, Westervelt P, Hegde P, Mukherjee D, Martens MJ, Logan B, Horowitz M, Hourigan CS, Nakamura R, Cutler C, Lindsley RC, Blood and Marrow Transplant Clinical Trials Network) J Clin Oncol 2023 Oct 01;41(28):4497-4510 PMID: 37607457 PMCID: PMC10552956 SCOPUS ID: 2-s2.0-85175320632 08/23/2023       8 Citations
  • Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. (Leiding JW, Arnold DE, Parikh S, Logan B, Marsh RA, Griffith LM, Wu R, Kidd S, Mallhi K, Chellapandian D, Si Lim SJ, Grunebaum E, Falcone EL, Murguia-Favela L, Grossman D, Prasad VK, Heimall JR, Touzot F, Burroughs LM, Bleesing J, Kapoor N, Dara J, Williams O, Kapadia M, Oshrine BR, Bednarski JJ, Rayes A, Chong H, Cuvelier GDE, Forbes Satter LR, Martinez C, Vander Lugt MT, Yu LC, Chandrakasan S, Joshi A, Prockop SE, Dávila Saldaña BJ, Aquino V, Broglie LA, Ebens CL, Madden LM, DeSantes K, Milner J, Rangarajan HG, Shah AJ, Gillio AP, Knutsen AP, Miller HK, Moore TB, Graham P, Bauchat A, Bunin NJ, Teira P, Petrovic A, Chandra S, Abdel-Azim H, Dorsey MJ, Birbrayer O, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Malech HL, Kang EM) Blood 2023 Dec 14;142(24):2105-2118 PMID: 37562003 PMCID: PMC10862239 SCOPUS ID: 2-s2.0-85172777713 08/10/2023       5 Citations
  • Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. (Logan BR, Fu D, Howard A, Fei M, Kou J, Little MR, Adom D, Mohamed FA, Blazar BR, Gafken PR, Paczesny S) J Clin Invest 2023 Aug 01;133(15) PMID: 37526081 PMCID: PMC10378149 SCOPUS ID: 2-s2.0-85166396305 08/01/2023       1 Citation
  • Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401. (Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Somaiya Dutt P, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D) Clin Cancer Res 2023 Dec 01;29(23):4784-4796 PMID: 37463058 PMCID: PMC10690096 SCOPUS ID: 2-s2.0-85178651085 07/18/2023       3 Citations
  • Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis. (Cho C, Devlin S, Maloy M, Horowitz MM, Logan B, Rizzo JD, Giralt SA, Perales MA) Bone Marrow Transplant 2023 Oct;58(10):1089-1095 PMID: 37422574 PMCID: PMC10592419 SCOPUS ID: 2-s2.0-85164194423 07/09/2023    
  • Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. (Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, O'Reilly RJ, Kapoor N, Satter LF, Pai SY, Heimall J, Chandra S, Ebens CL, Chellapandian D, Williams O, Burroughs LM, Saldana BD, Rayes A, Madden LM, Chandrakasan S, Bednarski JJ 2nd, DeSantes KB, Cuvelier GDE, Teira P, Gillio AP, Eissa H, Knutsen AP, Goldman FD, Aquino VM, Shereck EB, Moore TB, Caywood EH, Lugt MTV, Rozmus J, Broglie L, Yu LC, Shah AJ, Andolina JR, Liu X, Parrott RE, Dara J, Prockop S, Martinez CA, Kapadia M, Jyonouchi SC, Sullivan KE, Bleesing JJ, Chaudhury S, Petrovic A, Keller MD, Quigg TC, Parikh S, Shenoy S, Seroogy C, Rubin T, Decaluwe H, Routes JM, Torgerson TR, Leiding JW, Pulsipher MA, Kohn DB, Griffith LM, Haddad E, Dvorak CC, Notarangelo LD) Lancet 2023 Jul 08;402(10396):129-140 PMID: 37352885 PMCID: PMC10386791 SCOPUS ID: 2-s2.0-85164261929 06/24/2023       12 Citations
  • Worldwide sources of data in haematology: Importance of clinician-biostatistician collaboration. (Page KM, Spellman SR, Logan BR) Best Pract Res Clin Haematol 2023 Jun;36(2):101450 PMID: 37353283 SCOPUS ID: 2-s2.0-85150348533 06/24/2023    
  • Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers. (Sharma A, Logan B, Estrada-Merly N, Lehmann LE, Rangarajan HG, Preussler JM, Troy JD, Akard LP, Bhatt NS, Truong TH, Wood WA, Strouse C, Juckett M, Khera N, Rizzo D, Saber W) Transplant Cell Ther 2023 Aug;29(8):523-528 PMID: 37220838 SCOPUS ID: 2-s2.0-85163402644 05/24/2023       1 Citation
  • Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101. (El Jurdi N, Martens MJ, Brunstein CG, O'Donnell P, Lee SJ, D'Souza A, Logan B, Hong S, Singh AK, Sandhu K, Shapiro RM, Horowitz MM, Hamilton BK) Transplant Cell Ther 2023 Jul;29(7):467.e1-467.e5 PMID: 37088401 PMCID: PMC10330136 SCOPUS ID: 2-s2.0-85162230932 04/24/2023       1 Citation
  • Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic. (Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, Stefanski HE, Auletta JJ, Logan BR, Shaw BE) Blood Adv 2023 Oct 10;7(19):5982-5993 PMID: 37036959 PMCID: PMC10580174 SCOPUS ID: 2-s2.0-85172442056 04/11/2023       5 Citations
  • Nonparametric failure time: Time-to-event machine learning with heteroskedastic Bayesian additive regression trees and low information omnibus Dirichlet process mixtures. (Sparapani RA, Logan BR, Maiers MJ, Laud PW, McCulloch RE) Biometrics 2023 Dec;79(4):3023-3037 PMID: 36932826 PMCID: PMC10505620 SCOPUS ID: 2-s2.0-85153305626 03/19/2023    
  • Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. (Guru Murthy GS, Logan BR, Bo-Subait S, Beitinjaneh A, Devine S, Farhadfar N, Gowda L, Hashmi S, Lazarus H, Nathan S, Sharma A, Yared JA, Stefanski HE, Pulsipher MA, Hsu JW, Switzer GE, Panch SR, Shaw BE) Am J Hematol 2023 Apr;98(4):608-619 PMID: 36606713 PMCID: PMC10290878 SCOPUS ID: 2-s2.0-85146394154 01/07/2023       6 Citations
  • Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) Transplant Cell Ther 2023 Mar;29(3):208.e1-208.e6 PMID: 36584941 PMCID: PMC9992261 SCOPUS ID: 2-s2.0-85146784394 12/31/2022       8 Citations
  • Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation. (Friend BD, Broglie L, Logan BR, Chhabra S, Bupp C, Schiller G, Beitinjaneh A, Perez MAD, Guilcher GMT, Hashem H, Hildebrandt GC, Krem MM, Lazarus HM, Nishihori T, Nusrat R, Rotz SJ, Wirk B, Wieduwilt M, Pasquini M, Savani BN, Stadtmauer EA, Sorror ML, Thakar MS) Transplant Cell Ther 2023 Feb;29(2):123.e1-123.e10 PMID: 36442769 PMCID: PMC9911376 SCOPUS ID: 2-s2.0-85144499032 11/29/2022       3 Citations
  • Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases. (Broglie L, Friend BD, Chhabra S, Logan BR, Bupp C, Schiller G, Savani BN, Stadtmauer E, Abraham AA, Aljurf M, Badawy SM, Perez MAD, Guinan EC, Hashem H, Krem MM, Lazarus HM, Rotz SJ, Wirk B, Yared JA, Pasquini M, Thakar MS, Sorror ML) Transplant Cell Ther 2023 Feb;29(2):125.e1-125.e9 PMID: 36442768 PMCID: PMC9911359 SCOPUS ID: 2-s2.0-85144512149 11/29/2022       1 Citation
  • Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. (Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE) Am J Hematol 2023 Feb;98(2):229-250 PMID: 36251401 PMCID: PMC9839494 SCOPUS ID: 2-s2.0-85142150726 10/18/2022       5 Citations
  • Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. (Labrosse R, Boufaied I, Bourdin B, Gona S, Randolph HE, Logan BR, Bourbonnais S, Berthe C, Chan W, Buckley RH, Parrott RE, Cuvelier GDE, Kapoor N, Chandra S, Dávila Saldaña BJ, Eissa H, Goldman FD, Heimall J, O'Reilly R, Chaudhury S, Kolb EA, Shenoy S, Griffith LM, Pulsipher M, Kohn DB, Notarangelo LD, Pai SY, Cowan MJ, Dvorak CC, Haddad É, Puck JM, Barreiro LB, Decaluwe H) J Allergy Clin Immunol 2023 Jan;151(1):260-271 PMID: 35987350 PMCID: PMC9924130 SCOPUS ID: 2-s2.0-85138535551 08/21/2022       1 Citation
  • Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. (DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA) Lancet Haematol 2022 Sep;9(9):e660-e669 PMID: 35907408 PMCID: PMC9444987 SCOPUS ID: 2-s2.0-85135889621 07/31/2022       22 Citations
  • The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials. (Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, Panch S, Confer D, Liu H, Badawy SM, Beitinjaneh A, Diaz MA, Hildebrandt GC, Kelkar AH, Lazarus HM, Murthy HS, Preussler JM, Schears RM, Sharma A, van der Poel M, Bruce JG, Pulsipher MA, Shaw BE, Wingard JR, Switzer GE) Transplant Cell Ther 2022 Sep;28(9):603.e1-603.e7 PMID: 35688325 PMCID: PMC9427696 SCOPUS ID: 2-s2.0-85134804662 06/11/2022       5 Citations
  • Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. (Cuvelier GDE, Logan BR, Prockop SE, Buckley RH, Kuo CY, Griffith LM, Liu X, Yip A, Hershfield MS, Ayoub PG, Moore TB, Dorsey MJ, O'Reilly RJ, Kapoor N, Pai SY, Kapadia M, Ebens CL, Forbes Satter LR, Burroughs LM, Petrovic A, Chellapandian D, Heimall J, Shyr DC, Rayes A, Bednarski JJ, Chandra S, Chandrakasan S, Gillio AP, Madden L, Quigg TC, Caywood EH, Dávila Saldaña BJ, DeSantes K, Eissa H, Goldman FD, Rozmus J, Shah AJ, Vander Lugt MT, Thakar MS, Parrott RE, Martinez C, Leiding JW, Torgerson TR, Pulsipher MA, Notarangelo LD, Cowan MJ, Dvorak CC, Haddad E, Puck JM, Kohn DB) Blood 2022 Aug 18;140(7):685-705 PMID: 35671392 PMCID: PMC9389638 SCOPUS ID: 2-s2.0-85135995959 06/08/2022       25 Citations
  • Differential use of the hematopoietic cell transplantation-comorbidity index among adult and pediatric transplant physicians. (Broglie L, Friend BD, Chhabra S, Bupp C, Schiller GJ, Logan B, Pasquini MC, Savani B, Stadtmauer EA, Thakar MS, Sorror M) Leuk Lymphoma 2022 Oct;63(10):2507-2510 PMID: 35583292 PMCID: PMC9875328 SCOPUS ID: 2-s2.0-85130807981 05/19/2022       3 Citations
  • Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012. (Brunstein CG, O'Donnell PV, Logan B, Dawson P, Costa L, Cutler C, Craig M, Hogan W, Horowitz MM, Horwitz ME, Karanes C, Magenau JM, Malone A, McCarty J, McGuirk JP, Morris LE, Rezvani AR, Salit R, Vasu S, Eapen M, Fuchs EJ, Blood and Marrow Transplant Clinical Trials Network) Transplant Cell Ther 2022 Jul;28(7):406.e1-406.e6 PMID: 35390529 PMCID: PMC9253061 SCOPUS ID: 2-s2.0-85130454080 04/08/2022       2 Citations
  • Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. (Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, Geller N, Giralt S, Heslop HE, Horowitz MM, Jones RJ, Litzow MR, Mendizabal A, Muffly L, Nemecek ER, O'Donnell L, O'Reilly RJ, Palencia R, Schetelig J, Shune L, Solomon SR, Vasu S, Ho VT, Perales MA) J Clin Oncol 2022 Feb 01;40(4):356-368 PMID: 34855460 PMCID: PMC8797487 SCOPUS ID: 2-s2.0-85123901255 12/03/2021       69 Citations
  • Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? (Wingard JR, Alexander BD, Baden LR, Chen M, Sugrue MW, Leather HL, Caliendo AM, Clancy CJ, Denning DW, Marty FM, Nguyen MH, Wheat LJ, Logan BR, Horowitz MM, Marr KA) Open Forum Infect Dis 2021 Oct;8(10):ofab441 PMID: 34631917 PMCID: PMC8496761 SCOPUS ID: 2-s2.0-85118939894 10/12/2021       3 Citations
  • Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM) Transplant Cell Ther 2021 Nov;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021       11 Citations
  • Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome. (Nakamura R, Saber W, Martens MJ, Ramirez A, Scott B, Oran B, Leifer E, Tamari R, Mishra A, Maziarz RT, McGuirk J, Westervelt P, Vasu S, Patnaik M, Kamble R, Forman SJ, Sekeres MA, Appelbaum F, Mendizabal A, Logan B, Horowitz M, Cutler C) J Clin Oncol 2021 Oct 20;39(30):3328-3339 PMID: 34106753 PMCID: PMC8791814 SCOPUS ID: 2-s2.0-85112086284 06/10/2021       70 Citations
  • Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome. (Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Devine SM, Fernandez HF, Giralt S, Hamadani M, Howard A, Maziarz RT, Porter DL, Warlick ED, Pasquini MC, Scott BL, Horwitz ME, Deeg HJ, Hourigan CS) JCO Precis Oncol 2021;5 PMID: 34036237 PMCID: PMC8140814 SCOPUS ID: 2-s2.0-85105451387 05/27/2021       19 Citations
  • Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation. (Kim HT, Logan B, Weisdorf DJ) Transplant Cell Ther 2021 Aug;27(8):650-657 PMID: 34004355 PMCID: PMC8489461 SCOPUS ID: 2-s2.0-85111042219 05/19/2021       7 Citations
  • Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning. (Logan BR, Maiers MJ, Sparapani RA, Laud PW, Spellman SR, McCulloch RE, Shaw BE) JCO Clin Cancer Inform 2021 May;5:494-507 PMID: 33950708 PMCID: PMC8443829 SCOPUS ID: 2-s2.0-85105478562 05/06/2021       16 Citations
  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) J Clin Oncol 2021 Jun 20;39(18):1971-1982 PMID: 33905264 PMCID: PMC8260905 SCOPUS ID: 2-s2.0-85108386444 04/28/2021       79 Citations
  • COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum. (Wingard JR, Ahn KW, Dandoy C, Perales MA, Wood WA, Logan B, Riches M, Rizzo JD) Transplant Cell Ther 2021 Jul;27(7):533-539 PMID: 33895401 PMCID: PMC8061634 SCOPUS ID: 2-s2.0-85107113196 04/26/2021       1 Citation
  • The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. (Hsu JW, Farhadfar N, Murthy H, Logan BR, Bo-Subait S, Frey N, Goldstein SC, Horowitz MM, Lazarus H, Schwanke JD, Shah NN, Spellman SR, Switzer GE, Devine SM, Shaw BE, Wingard JR) Transplant Cell Ther 2021 Jun;27(6):507-516 PMID: 33865804 PMCID: PMC8217124 SCOPUS ID: 2-s2.0-85108052714 04/19/2021       25 Citations
  • Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study. (Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, Confer DL, Shaw BE, Pulsipher MA) Transplant Cell Ther 2021 Apr;27(4):352.e1-352.e5 PMID: 33836890 PMCID: PMC8036235 SCOPUS ID: 2-s2.0-85101149566 04/11/2021       3 Citations
  • Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. (Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF) Transplant Cell Ther 2021 Jun;27(6):503.e1-503.e8 PMID: 33823169 PMCID: PMC8217152 SCOPUS ID: 2-s2.0-85103924669 04/07/2021       1 Citation
  • Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers (Journal of Clinical Immunology, (2021), 41, 1, (38-50), 10.1007/s10875-020-00865-9) (Dorsey M, Wright NAM, Chaimowitz NS, Dávila Saldaña BJ, Miller H, Keller MD, Thakar MS, Shah AJ, Abu-Arja R, Andolina J, Aquino V, Barnum JL, Bednarski JJ, Bhatia M, Bonilla FA, Butte MJ, Bunin NJ, Burroughs LM, Chandra S, Chaudhury S, Chen K, Chong H, Cuvelier G, Dalal J, DeFelice ML, DeSantes KB, Forbes LR, Gillio A, Goldman F, Joshi AY, Kapoor N, Knutsen AP, Kobrynski L, Lieberman JA, Leiding JW, Oshrine B, Patel KP, Prockop S, Quigg TC, Quinones R, Schultz KR, Seroogy C, Shyr D, Siegel S, Smith AR, Torgerson TR, Vander Lugt MT, Yu LC, Cowan MJ, Buckley RH, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Logan B, Notarangelo LD, Pai SY, Puck J, Pulsipher MA, Heimall J) Journal of Clinical Immunology February 2021;41(2):498-500 SCOPUS ID: 2-s2.0-85097099334 02/01/2021    
  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. (Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG) Blood 2021 Jan 21;137(3):420-428 PMID: 33475736 PMCID: PMC7819761 SCOPUS ID: 2-s2.0-85092507677 01/22/2021       115 Citations
  • Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers (Dorsey MJ, Wright NAM, Chaimowitz NS, Dávila Saldaña BJ, Miller H, Keller MD, Thakar MS, Shah AJ, Abu-Arja R, Andolina J, Aquino V, Barnum JL, Bednarski JJ, Bhatia M, Bonilla FA, Butte MJ, Bunin NJ, Chandra S, Chaudhury S, Chen K, Chong H, Cuvelier GDE, Dalal J, DeFelice ML, DeSantes KB, Forbes LR, Gillio A, Goldman F, Joshi AY, Kapoor N, Knutsen AP, Kobrynski L, Lieberman JA, Leiding JW, Oshrine B, Patel KP, Prockop S, Quigg TC, Quinones R, Schultz KR, Seroogy C, Shyr D, Siegel S, Smith AR, Torgerson TR, Vander Lugt MT, Yu LC, Cowan MJ, Buckley RH, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Logan B, Notarangelo LD, Pai SY, Puck J, Pulsipher MA, Heimall J) Journal of Clinical Immunology January 2021;41(1):38-50 SCOPUS ID: 2-s2.0-85091786239 01/01/2021       34 Citations
  • A unified approach to sample size and power determination for testing parameters in generalized linear and time-to-event regression models. (Martens MJ, Logan BR) Stat Med 2021 Feb 28;40(5):1121-1132 PMID: 33210321 PMCID: PMC8020892 SCOPUS ID: 2-s2.0-85096664064 11/20/2020       5 Citations
  • Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation Studies. (Kim S, Logan B, Riches M, Chen M, Ahn KW) Transplant Cell Ther 2021 Feb;27(2):125-132 PMID: 33017663 PMCID: PMC8015678 SCOPUS ID: 2-s2.0-85093960710 10/06/2020       6 Citations
  • Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. (Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Martinez C, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium) J Clin Immunol 2020 Nov;40(8):1211-1213 PMID: 32860171 PMCID: PMC11060430 SCOPUS ID: 2-s2.0-85089900632 08/30/2020       2 Citations
  • Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. (Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Bone Marrow Transplant 2021 Feb;56(2):522 PMID: 32514157 PMCID: PMC7722110 SCOPUS ID: 2-s2.0-85086026026 06/10/2020    
  • Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. (Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Bone Marrow Transplant 2020 Nov;55(11):2121-2131 PMID: 32355289 PMCID: PMC7606543 SCOPUS ID: 2-s2.0-85085105399 05/02/2020       9 Citations
  • Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. (Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ) Blood 2020 Jun 04;135(23):2094-2105 PMID: 32268350 PMCID: PMC7273831 SCOPUS ID: 2-s2.0-85086008168 04/09/2020       75 Citations
  • Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. (Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M, Gennery AR, Smith AR, Pai SY, Jordan MB, Marsh RA, Cowan MJ, Dvorak CC, Craddock JA, Prockop SE, Chandrakasan S, Kapoor N, Buckley RH, Parikh S, Chellapandian D, Oshrine BR, Bednarski JJ, Cooper MA, Shenoy S, Davila Saldana BJ, Forbes LR, Martinez C, Haddad E, Shyr DC, Chen K, Sullivan KE, Heimall J, Wright N, Bhatia M, Cuvelier GDE, Goldman FD, Meyts I, Miller HK, Seidel MG, Vander Lugt MT, Bacchetta R, Weinacht KG, Andolina JR, Caywood E, Chong H, de la Morena MT, Aquino VM, Shereck E, Walter JE, Dorsey MJ, Seroogy CM, Griffith LM, Kohn DB, Puck JM, Pulsipher MA, Torgerson TR) Front Immunol 2020;11:239 PMID: 32153572 PMCID: PMC7046837 SCOPUS ID: 2-s2.0-85081208356 03/11/2020       54 Citations
  • Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management. (Seftel MD, Kuxhausen M, Burns L, Chitphakdithai P, Confer D, Kiefer D, Lee S, Logan B, O'Donnell P, Pulsipher M, Shah NN, Switzer G, Shaw BE) Biol Blood Marrow Transplant 2020 Jun;26(6):e142-e144 PMID: 32147534 PMCID: PMC7440392 SCOPUS ID: 2-s2.0-85085163476 03/10/2020       7 Citations
  • Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. (Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M) Br J Haematol 2020 Jun;189(6):1171-1181 PMID: 32124435 PMCID: PMC7726817 SCOPUS ID: 2-s2.0-85080995146 03/04/2020       61 Citations
  • Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. (Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Blood Adv 2020 Feb 25;4(4):706-716 PMID: 32092138 PMCID: PMC7042992 SCOPUS ID: 2-s2.0-85082202343 02/25/2020       11 Citations
  • Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors. (Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR) Biol Blood Marrow Transplant 2020 Jun;26(6):1210-1217 PMID: 32088366 PMCID: PMC7347029 SCOPUS ID: 2-s2.0-85082823451 02/24/2020       4 Citations
  • Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial. (Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW) Blood Adv 2020 Feb 11;4(3):467-476 PMID: 32027744 PMCID: PMC7013267 SCOPUS ID: 2-s2.0-85082178004 02/07/2020       37 Citations
  • Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. (Hourigan CS, Dillon LW, Gui G, Logan BR, Fei M, Ghannam J, Li Y, Licon A, Alyea EP, Bashey A, Deeg HJ, Devine SM, Fernandez HF, Giralt S, Hamadani M, Howard A, Maziarz RT, Porter DL, Scott BL, Warlick ED, Pasquini MC, Horwitz ME) J Clin Oncol 2020 Apr 20;38(12):1273-1283 PMID: 31860405 PMCID: PMC7164487 SCOPUS ID: 2-s2.0-85083545151 12/21/2019       268 Citations
  • Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study. (Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD) JAMA Oncol 2020 Apr 01;6(4):486-493 PMID: 31830234 PMCID: PMC6990739 SCOPUS ID: 2-s2.0-85076620276 12/13/2019       39 Citations
  • Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia. (Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW) JNCI Cancer Spectr 2019 Dec;3(4):pkz073 PMID: 31763620 PMCID: PMC6859844 SCOPUS ID: 2-s2.0-85085522039 11/26/2019       18 Citations
  • Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial. (Giralt S, Costa LJ, Maloney D, Krishnan A, Fei M, Antin JH, Brunstein C, Geller N, Goodman S, Hari P, Logan B, Lowsky R, Qazilbash MH, Sahebi F, Somlo G, Rowley S, Vogl DT, Vesole DH, Pasquini M, Stadtmauer E) Biol Blood Marrow Transplant 2020 Apr;26(4):798-804 PMID: 31756536 PMCID: PMC7198329 SCOPUS ID: 2-s2.0-85077165933 11/23/2019       26 Citations
  • Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients. (Ballen K, Logan BR, Chitphakdithai P, Kuxhausen M, Spellman SR, Adams A, Drexler RJ, Duffy M, Kemp A, King R, Babic A, Delaney C, Karanes C, Kurtzberg J, Petz L, Scaradavou A, Shpall EJ, Smith C, Confer DL, Miller JP) Biol Blood Marrow Transplant 2020 Apr;26(4):745-757 PMID: 31756539 PMCID: PMC7198366 SCOPUS ID: 2-s2.0-85077166820 11/23/2019       11 Citations
  • Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults. (Majhail NS, Mau LW, Chitphakdithai P, Denzen EM, Joffe S, Lee SJ, LeMaistre CF, Loberiza F, Parsons SK, Repaczki-Jones R, Robinett P, Douglas Rizzo J, Murphy E, Logan B, Le-Rademacher J) Bone Marrow Transplant 2020 May;55(5):906-917 PMID: 31740767 PMCID: PMC7202970 SCOPUS ID: 2-s2.0-85075369259 11/20/2019       33 Citations
  • Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial. (Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JLM, Levine JE, Mielcarek M, Anasetti C, Antin JH, Bolaños-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML) Blood 2020 Jan 09;135(2):97-107 PMID: 31738834 PMCID: PMC6952830 SCOPUS ID: 2-s2.0-85077761109 11/19/2019       55 Citations
  • Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point. (Martens MJ, Logan BR) Lifetime Data Anal 2020 Jul;26(3):603-623 PMID: 31729633 PMCID: PMC7365590 SCOPUS ID: 2-s2.0-85075483839 11/16/2019       1 Citation
  • Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. (Shah AJ, Sokolic R, Logan B, Yin Z, Iyengar S, Scalchunes C, Mangurian C, Albert M, Cowan MJ) J Clin Immunol 2019 Nov;39(8):786-794 PMID: 31620947 PMCID: PMC7385986 SCOPUS ID: 2-s2.0-85074594346 10/18/2019       10 Citations
  • Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. (Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC) Biol Blood Marrow Transplant 2020 Feb;26(2):333-342 PMID: 31563573 PMCID: PMC6943183 SCOPUS ID: 2-s2.0-85074484312 09/30/2019       27 Citations
  • Factors Associated With Successful Discontinuation of Immune Suppression After Allogeneic Hematopoietic Cell Transplantation. (Pidala J, Martens M, Anasetti C, Carreras J, Horowitz M, Lee SJ, Antin J, Cutler C, Logan B) JAMA Oncol 2020 Jan 01;6(1):e192974 PMID: 31556923 PMCID: PMC6763979 SCOPUS ID: 2-s2.0-85072756041 09/27/2019       13 Citations
  • Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. (Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM, submitted on behalf of the Primary Immune Deficiency Treatment Consortium) J Clin Immunol 2019 Oct;39(7):653-667 PMID: 31376032 PMCID: PMC6754755 SCOPUS ID: 2-s2.0-85072546464 08/04/2019       38 Citations
  • Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study (Mangurian C, Scalchunes C, Yoo J, Logan B, Henderson T, Iyengar S, Smith H, Cowan MJ) Palliative and Supportive Care 1 August 2019;17(4):409-414 SCOPUS ID: 2-s2.0-85053733047 08/01/2019       1 Citation
  • Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. (Waller EK, Logan BR, Fei M, Lee SJ, Confer D, Howard A, Chandrakasan S, Anasetti C, Fernando SM, Giver CR) Blood Adv 2019 Aug 13;3(15):2250-2263 PMID: 31345792 PMCID: PMC6693008 SCOPUS ID: 2-s2.0-85070756125 07/28/2019       30 Citations
  • Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial. (Ambinder RF, Wu J, Logan B, Durand CM, Shields R, Popat UR, Little RF, McMahon DK, Cyktor J, Mellors JW, Ayala E, Kaplan LD, Noy A, Jones RJ, Howard A, Forman SJ, Porter D, Arce-Lara C, Shaughnessy P, Sproat L, Hashmi SK, Mendizabal AM, Horowitz MM, Navarro WH, Alvarnas JC) Biol Blood Marrow Transplant 2019 Nov;25(11):2160-2166 PMID: 31279752 PMCID: PMC6907401 SCOPUS ID: 2-s2.0-85069900077 07/08/2019       27 Citations
  • Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study". (Hurley CK, Spellman S, Dehn J, Barker JN, Devine S, Fernandez-Vina M, Gautreaux M, Logan B, Maiers M, Mueller C, Perales MA, Yu N, Pidala J) Biol Blood Marrow Transplant 2019 Aug;25(8):e268-e269 PMID: 31145991 SCOPUS ID: 2-s2.0-85070694182 05/31/2019       6 Citations
  • Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors. (Wiener L, Hoag JA, Pelletier W, Shah NN, Shaw BE, Pulsipher MA, Bruce J, Bader P, Willasch AM, Dalissier A, Guilcher G, Anthias C, Confer DL, Sees JA, Logan B, Switzer GE) Bone Marrow Transplant 2019 Nov;54(11):1780-1788 PMID: 30971776 PMCID: PMC6961459 SCOPUS ID: 2-s2.0-85064094294 04/12/2019       9 Citations
  • Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors. (Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL) AJNR Am J Neuroradiol 2019 Apr;40(4):626-633 PMID: 30923088 PMCID: PMC6461489 SCOPUS ID: 2-s2.0-85064588009 03/30/2019       33 Citations
  • Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203). (Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J) Lancet Haematol 2019 Mar;6(3):e132-e143 PMID: 30824040 PMCID: PMC6503965 SCOPUS ID: 2-s2.0-85061920512 03/03/2019       185 Citations
  • Learning the Dynamic Treatment Regimes from Medical Registry Data through Deep Q-network. (Liu N, Liu Y, Logan B, Xu Z, Tang J, Wang Y) Sci Rep 2019 Feb 06;9(1):1495 PMID: 30728403 PMCID: PMC6365640 SCOPUS ID: 2-s2.0-85061117758 02/08/2019       18 Citations
  • The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. (Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2019 Jul;25(7):1325-1330 PMID: 30716454 PMCID: PMC6615955 SCOPUS ID: 2-s2.0-85062227022 02/05/2019       14 Citations
  • Nonparametric competing risks analysis using Bayesian Additive Regression Trees. (Sparapani R, Logan BR, McCulloch RE, Laud PW) Stat Methods Med Res 2020 Jan;29(1):57-77 PMID: 30612519 PMCID: PMC6954340 SCOPUS ID: 2-s2.0-85060347965 01/08/2019       16 Citations
  • Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE) Biol Blood Marrow Transplant 2019 May;25(5):955-964 PMID: 30605731 PMCID: PMC6511296 SCOPUS ID: 2-s2.0-85061429566 01/04/2019       7 Citations
  • FULLY NONPARAMETRIC BAYESIAN ADDITIVE REGRESSION TREES (George E, Laud P, Logan B, McCulloch R, Sparapani R) Advances in Econometrics 2019;40B:89-110 SCOPUS ID: 2-s2.0-85135159674 01/01/2019       8 Citations
  • The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. (Thakar MS, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, Sorror ML) Blood 2019 Feb 14;133(7):754-762 PMID: 30545834 PMCID: PMC6376282 SCOPUS ID: 2-s2.0-85061488564 12/14/2018       36 Citations
  • Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. (Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2019 Apr;25(4):699-711 PMID: 30423480 PMCID: PMC6453753 SCOPUS ID: 2-s2.0-85058455309 11/14/2018       11 Citations
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE) Haematologica 2019 Apr;104(4):844-854 PMID: 30381298 PMCID: PMC6442962 SCOPUS ID: 2-s2.0-85064008651 11/02/2018       12 Citations
  • Psychosocial services for primary immunodeficiency disorder families during hematopoietic cell transplantation: A descriptive study. (Mangurian C, Scalchunes C, Yoo J, Logan B, Henderson T, Iyengar S, Smith H, Cowan MJ) Palliat Support Care 2019 Aug;17(4):409-414 PMID: 30223912 PMCID: PMC6422770 SCOPUS ID: 2-s2.0-85053733047 09/19/2018       1 Citation
  • The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). (Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, Kohn DB, Pai SY, Notarangelo L, Shearer W, Prockop S, Kapoor N, Heimall J, Chaudhury S, Shyr D, Chandra S, Cuvelier G, Moore T, Shenoy S, Goldman F, Smith AR, Sunkersett G, Vander Lugt M, Caywood E, Quigg T, Torgerson T, Chandrakasan S, Craddock J, Dávila Saldaña BJ, Gillio A, Shereck E, Aquino V, DeSantes K, Knutsen A, Thakar M, Yu L, Puck JM) J Allergy Clin Immunol 2019 Jan;143(1):405-407 PMID: 30193840 PMCID: PMC6322970 SCOPUS ID: 2-s2.0-85054131174 09/09/2018       63 Citations
  • SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. (Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD) Blood 2018 Oct 25;132(17):1737-1749 PMID: 30154114 PMCID: PMC6202916 SCOPUS ID: 2-s2.0-85055612463 08/30/2018       125 Citations
  • Testing for center effects on survival and competing risks outcomes using pseudo-value regression. (Wang Y, Logan BR) Lifetime Data Anal 2019 Apr;25(2):206-228 PMID: 29978275 PMCID: PMC6320737 SCOPUS ID: 2-s2.0-85049594054 07/07/2018       1 Citation
  • A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801. (Carpenter PA, Logan BR, Lee SJ, Weisdorf DJ, Johnston L, Costa LJ, Kitko CL, Bolaños-Meade J, Sarantopoulos S, Alousi AM, Abhyankar S, Waller EK, Mendizabal A, Zhu J, O'Brien KA, Lazaryan A, Wu J, Nemecek ER, Pavletic SZ, Cutler CS, Horowitz MM, Arora M, BMT CTN.) Haematologica 2018 Nov;103(11):1915-1924 PMID: 29954931 PMCID: PMC6278959 SCOPUS ID: 2-s2.0-85055802370 06/30/2018       30 Citations
  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. (Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA) Biol Blood Marrow Transplant 2018 Oct;24(10):2040-2046 PMID: 29933069 PMCID: PMC6239928 SCOPUS ID: 2-s2.0-85050818070 06/23/2018       29 Citations
  • Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project. (Schmainda KM, Prah MA, Rand SD, Liu Y, Logan B, Muzi M, Rane SD, Da X, Yen YF, Kalpathy-Cramer J, Chenevert TL, Hoff B, Ross B, Cao Y, Aryal MP, Erickson B, Korfiatis P, Dondlinger T, Bell L, Hu L, Kinahan PE, Quarles CC) AJNR Am J Neuroradiol 2018 Jun;39(6):1008-1016 PMID: 29794239 PMCID: PMC6002911 SCOPUS ID: 2-s2.0-85048696048 05/26/2018       38 Citations
  • Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. (Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD) BMC Cancer 2018 May 24;18(1):593 PMID: 29793446 PMCID: PMC5968588 SCOPUS ID: 2-s2.0-85047544800 05/26/2018       28 Citations
  • A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. (Moodie EEM, Stephens DA, Alam S, Zhang MJ, Logan B, Arora M, Spellman S, Krakow EF) Biom J 2019 Mar;61(2):442-453 PMID: 29766558 PMCID: PMC6239975 SCOPUS ID: 2-s2.0-85047468536 05/17/2018       5 Citations
  • B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. (Miggelbrink AM, Logan BR, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Abdel-Azim H, Prockop SE, Shyr D, Decaluwe H, Hanson IC, Gillio A, Dávila Saldaña BJ, Eibel H, Hopkins G, Walter JE, Whangbo JS, Kohn DB, Puck JM, Cowan MJ, Griffith LM, Haddad E, O'Reilly RJ, Notarangelo LD, Pai SY) Blood 2018 Jun 28;131(26):2967-2977 PMID: 29728406 PMCID: PMC6024640 SCOPUS ID: 2-s2.0-85049141956 05/08/2018       33 Citations
  • A group sequential test for treatment effect based on the Fine-Gray model. (Martens MJ, Logan BR) Biometrics 2018 Sep;74(3):1006-1013 PMID: 29534294 PMCID: PMC6146968 SCOPUS ID: 2-s2.0-85043497709 03/14/2018       4 Citations
  • Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ) Biol Blood Marrow Transplant 2018 May;24(5):1049-1056 PMID: 29454040 PMCID: PMC5953795 SCOPUS ID: 2-s2.0-85043996138 02/18/2018       94 Citations
  • Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials. (Pasquini MC, Logan B, Jones RJ, Alousi AM, Appelbaum FR, Bolaños-Meade J, Flowers MED, Giralt S, Horowitz MM, Jacobsohn D, Koreth J, Levine JE, Luznik L, Maziarz R, Mendizabal A, Pavletic S, Perales MA, Porter D, Reshef R, Weisdorf D, Antin JH) Biol Blood Marrow Transplant 2018 Jun;24(6):1274-1280 PMID: 29325830 PMCID: PMC5993573 SCOPUS ID: 2-s2.0-85041672720 01/13/2018       39 Citations
  • Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees. (Logan BR, Sparapani R, McCulloch RE, Laud PW) Stat Methods Med Res 2019 Apr;28(4):1079-1093 PMID: 29254443 PMCID: PMC6028324 SCOPUS ID: 2-s2.0-85043704690 12/20/2017       29 Citations
  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. (Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Pulsipher MA, Parikh S, Martinez C, Kapoor N, O'Reilly R, Boyer M, Pai SY, Goldman F, Burroughs L, Chandra S, Kletzel M, Thakar M, Connelly J, Cuvelier G, Davila Saldana BJ, Shereck E, Knutsen A, Sullivan KE, DeSantes K, Gillio A, Haddad E, Petrovic A, Quigg T, Smith AR, Stenger E, Yin Z, Shearer WT, Fleisher T, Buckley RH, Dvorak CC) Blood 2017 Dec 21;130(25):2718-2727 PMID: 29021228 PMCID: PMC5746165 SCOPUS ID: 2-s2.0-85039152986 10/13/2017       182 Citations
  • Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. (Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2018 Jan;24(1):175-184 PMID: 28958894 PMCID: PMC5743544 SCOPUS ID: 2-s2.0-85033230771 09/30/2017       5 Citations
  • Deep Reinforcement Learning for Dynamic Treatment Regimes on Medical Registry Data (Liu Y, Logan B, Liu N, Xu Z, Tang J, Wang Y) Proceedings - 2017 IEEE International Conference on Healthcare Informatics, ICHI 2017 8 September 2017:380-385 SCOPUS ID: 2-s2.0-85032350439 09/08/2017       77 Citations
  • Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning. (Krakow EF, Hemmer M, Wang T, Logan B, Arora M, Spellman S, Couriel D, Alousi A, Pidala J, Last M, Lachance S, Moodie EEM) Am J Epidemiol 2017 Jul 15;186(2):160-172 PMID: 28472335 PMCID: PMC6664807 SCOPUS ID: 2-s2.0-85029668317 05/05/2017       29 Citations
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. (Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP, Hamadani M, Bashey A, Giralt S, Geller NL, Leifer E, Le-Rademacher J, Mendizabal AM, Horowitz MM, Deeg HJ, Horwitz ME) J Clin Oncol 2017 Apr 10;35(11):1154-1161 PMID: 28380315 PMCID: PMC5455603 SCOPUS ID: 2-s2.0-85017300040 04/06/2017       467 Citations
  • Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. (Abu Zaid M, Wu J, Wu C, Logan BR, Yu J, Cutler C, Antin JH, Paczesny S, Choi SW) Blood 2017 Jan 12;129(2):162-170 PMID: 27827824 PMCID: PMC5234220 SCOPUS ID: 2-s2.0-85018440780 11/10/2016       62 Citations
  • The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes. (Artz AS, Logan B, Zhu X, Akpek G, Bufarull RM, Gupta V, Lazarus HM, Litzow M, Loren A, Majhail NS, Maziarz RT, McCarthy P, Popat U, Saber W, Spellman S, Ringden O, Wickrema A, Pasquini MC, Cooke KR, from the Center for International Blood and Marrow Transplantation Research) Haematologica 2016 Nov;101(11):1426-1433 PMID: 27662010 PMCID: PMC5394859 SCOPUS ID: 2-s2.0-84994651188 11/02/2016       50 Citations
  • Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). (Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee SJ) Biol Blood Marrow Transplant 2017 Jan;23(1):161-164 PMID: 27742574 PMCID: PMC5182134 SCOPUS ID: 2-s2.0-85006489235 10/16/2016       9 Citations
  • A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 PMID: 27625358 PMCID: PMC5123194 SCOPUS ID: 2-s2.0-85015019083 09/15/2016       153 Citations
  • Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial. (Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD) Biol Blood Marrow Transplant 2016 Dec;22(12):2256-2263 PMID: 27565521 PMCID: PMC5116244 SCOPUS ID: 2-s2.0-84992110582 08/28/2016       23 Citations
  • Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 SCOPUS ID: 2-s2.0-85013156188 08/18/2016       95 Citations
  • Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis. (O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs EJ, Flowers ME, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Furst S, Blaise D) Bone Marrow Transplant 2016 Dec;51(12):1599-1601 PMID: 27526284 PMCID: PMC5143194 SCOPUS ID: 2-s2.0-84982085195 08/16/2016       38 Citations
  • Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. (Belle L, Agle K, Zhou V, Yin-Yuan C, Komorowski R, Eastwood D, Logan B, Sun J, Ghilardi N, Cua D, Williams CB, Gaignage M, Marillier R, van Snick J, Drobyski WR) Blood 2016 Oct 20;128(16):2068-2082 PMID: 27488350 PMCID: PMC5073185 SCOPUS ID: 2-s2.0-84992051377 08/05/2016       34 Citations
  • A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. (Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S) Bone Marrow Transplant 2017 Jan;52(1):59-65 PMID: 27427921 PMCID: PMC5215562 SCOPUS ID: 2-s2.0-84978696407 07/19/2016       17 Citations
  • Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. (D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer E, Maloney D, Hari P) Br J Haematol 2017 Sep;178(5):816-819 PMID: 27292583 PMCID: PMC5154782 SCOPUS ID: 2-s2.0-84994285799 06/14/2016       2 Citations
  • PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA. (Ahn KW, Logan BR) Ann Appl Stat 2016 Jun;10(2):618-637 PMID: 29081872 PMCID: PMC5656291 SCOPUS ID: 2-s2.0-84979879974 06/01/2016       4 Citations
  • Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. (Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Aug;22(8):1440-1448 PMID: 27118571 PMCID: PMC4949103 SCOPUS ID: 2-s2.0-84973901396 04/28/2016       40 Citations
  • Pseudo-value regression models (Logan BR, Wang T) Handbook of Survival Analysis 19 April 2016:199-219 SCOPUS ID: 2-s2.0-85123270259 04/19/2016       2 Citations
  • Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201. (Burns LJ, Logan BR, Chitphakdithai P, Miller JP, Drexler R, Spellman S, Switzer GE, Wingard JR, Anasetti C, Confer DL, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2016 Jun;22(6):1108-1116 PMID: 27013014 PMCID: PMC4867293 SCOPUS ID: 2-s2.0-84964336993 03/26/2016       22 Citations
  • Nonparametric survival analysis using Bayesian Additive Regression Trees (BART). (Sparapani RA, Logan BR, McCulloch RE, Laud PW) Stat Med 2016 Jul 20;35(16):2741-53 PMID: 26854022 PMCID: PMC4899272 SCOPUS ID: 2-s2.0-84978975552 02/09/2016       95 Citations
  • Observational Studies: Matching or Regression? (Brazauskas R, Logan BR) Biol Blood Marrow Transplant 2016 Mar;22(3):557-63 PMID: 26712591 PMCID: PMC4756459 SCOPUS ID: 2-s2.0-85009461542 12/30/2015       71 Citations
  • Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. (Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV) Biol Blood Marrow Transplant 2016 Mar;22(3):520-7 PMID: 26597080 PMCID: PMC4760616 SCOPUS ID: 2-s2.0-84954290281 11/26/2015       11 Citations
  • European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. (Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2016 Mar;22(3):514-9 PMID: 26597079 PMCID: PMC4760354 SCOPUS ID: 2-s2.0-84954288117 11/26/2015       13 Citations
  • Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. (Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JWM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C, Blood and Marrow Transplant Clinical Trials Network Trial 0201) Biol Blood Marrow Transplant 2016 Feb;22(2):359-370 PMID: 26409243 PMCID: PMC4716871 SCOPUS ID: 2-s2.0-84958602733 09/27/2015       121 Citations
  • Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients. (Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JM, Ma J, Cole SW) Clin Cancer Res 2016 Jan 01;22(1):69-78 PMID: 26286914 PMCID: PMC4703514 SCOPUS ID: 2-s2.0-84954345425 08/20/2015       62 Citations
  • Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. (Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2015 Oct;21(10):1830-8 PMID: 26116089 PMCID: PMC4568129 SCOPUS ID: 2-s2.0-84941317226 06/28/2015       11 Citations
  • Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. (Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC) Biol Blood Marrow Transplant 2015 Aug;21(8):1479-87 PMID: 25862591 PMCID: PMC4512746 SCOPUS ID: 2-s2.0-84937713457 04/12/2015       162 Citations
  • National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. (Majhail NS, Mau LW, Chitphakdithai P, Payton T, Eckrich M, Joffe S, Lee SJ, LeMaistre CF, LeRademacher J, Loberiza F, Logan B, Parsons SK, Repaczki-Jones R, Robinett P, Rizzo JD, Murphy E, Denzen EM) Biol Blood Marrow Transplant 2015 Jul;21(7):1308-14 PMID: 25840337 PMCID: PMC4466059 SCOPUS ID: 2-s2.0-84930571638 04/04/2015       41 Citations
  • Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. (Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR) Leukemia 2015 Aug;29(8):1754-62 PMID: 25772027 PMCID: PMC4527886 SCOPUS ID: 2-s2.0-84938991869 03/17/2015       101 Citations
  • Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. (Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC) Biol Blood Marrow Transplant 2015 Jun;21(6):1046-1053 PMID: 25687795 PMCID: PMC4426014 SCOPUS ID: 2-s2.0-84943454051 02/18/2015       123 Citations
  • ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. (Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB, Center for International Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2015 Apr;21(4):746-54 PMID: 25572032 PMCID: PMC4363312 SCOPUS ID: 2-s2.0-84924256714 01/13/2015       36 Citations
  • Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. (Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WY, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M) Biol Blood Marrow Transplant 2015 Apr;21(4):688-95 PMID: 25543094 PMCID: PMC4359657 SCOPUS ID: 2-s2.0-84924284376 12/30/2014       14 Citations
  • Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. (Eapen M, Logan BR, Horowitz MM, Zhong X, Perales MA, Lee SJ, Rocha V, Soiffer RJ, Champlin RE) J Clin Oncol 2015 Feb 01;33(4):364-9 PMID: 25534391 PMCID: PMC4302216 SCOPUS ID: 2-s2.0-84921903392 12/24/2014       45 Citations
  • Blood and marrow transplant clinical trials network state of the Science Symposium 2014. (Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM) Biol Blood Marrow Transplant 2015 Feb;21(2):202-24 PMID: 25445636 PMCID: PMC4426907 SCOPUS ID: 2-s2.0-84920914015 12/03/2014       19 Citations
  • Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. (Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ) Biol Blood Marrow Transplant 2015 Mar;21(3):454-9 PMID: 25460355 PMCID: PMC4329076 SCOPUS ID: 2-s2.0-84922925469 12/03/2014       243 Citations
  • Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. (Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN, Hale G, Hartzman RJ, Karanes C, Laport GG, Nemecek E, Snyder EL, Switzer GE, Miller J, Navarro W, Confer DL, Levine JE) Biol Blood Marrow Transplant 2015 Jan;21(1):142-50 PMID: 25445638 PMCID: PMC4272902 SCOPUS ID: 2-s2.0-84927152756 12/03/2014       58 Citations
  • Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. (Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC) Bone Marrow Transplant 2015 Mar;50(3):367-74 PMID: 25437248 PMCID: PMC4351124 SCOPUS ID: 2-s2.0-84938416290 12/02/2014       9 Citations
  • Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 PMID: 25316111 PMCID: PMC4272878 SCOPUS ID: 2-s2.0-84927166294 10/16/2014       25 Citations
  • Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. (Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M, RCI BMT 05-DCB Protocol Team) Br J Haematol 2015 Feb;168(3):405-12 PMID: 25272241 PMCID: PMC5557396 SCOPUS ID: 2-s2.0-84921434405 10/02/2014       35 Citations
  • Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. (Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE) Biol Blood Marrow Transplant 2015 Jan;21(1):55-9 PMID: 25255165 PMCID: PMC4272909 SCOPUS ID: 2-s2.0-84927166028 09/26/2014       29 Citations
  • Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. (Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT) Blood 2014 Nov 20;124(22):3221-7; quiz 3335 PMID: 25170121 PMCID: PMC4239331 SCOPUS ID: 2-s2.0-84911435257 08/30/2014       84 Citations
  • Transplantation outcomes for severe combined immunodeficiency, 2000-2009. (Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, Sullivan KE, Small TN, Burroughs L, Skoda-Smith S, Haight AE, Grizzle A, Pulsipher MA, Chan KW, Fuleihan RL, Haddad E, Loechelt B, Aquino VM, Gillio A, Davis J, Knutsen A, Smith AR, Moore TB, Schroeder ML, Goldman FD, Connelly JA, Porteus MH, Xiang Q, Shearer WT, Fleisher TA, Kohn DB, Puck JM, Notarangelo LD, Cowan MJ, O'Reilly RJ) N Engl J Med 2014 Jul 31;371(5):434-46 PMID: 25075835 PMCID: PMC4183064 SCOPUS ID: 2-s2.0-84904876386 07/31/2014       568 Citations
  • Group sequential tests for long-term survival comparisons. (Logan BR, Mo S) Lifetime Data Anal 2015 Apr;21(2):218-40 PMID: 25053470 PMCID: PMC4305035 SCOPUS ID: 2-s2.0-84939875073 07/24/2014       4 Citations
  • Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. (Cutler C, Logan B, Nakamura R, Johnston L, Choi S, Porter D, Hogan WJ, Pasquini M, MacMillan ML, Hsu JW, Waller EK, Grupp S, McCarthy P, Wu J, Hu ZH, Carter SL, Horowitz MM, Antin JH) Blood 2014 Aug 21;124(8):1372-7 PMID: 24982504 PMCID: PMC4141519 SCOPUS ID: 2-s2.0-84907357105 07/02/2014       151 Citations
  • Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201. (Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C) J Clin Oncol 2014 Aug 01;32(22):2365-72 PMID: 24982459 PMCID: PMC4180368 SCOPUS ID: 2-s2.0-84905828126 07/02/2014       74 Citations
  • Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods. (Saber W, Le Rademacher J, Sekeres M, Logan B, Lewis M, Mendizabal A, Leifer E, Appelbaum FR, Horowitz MM, Nakamura R, Cutler CS) Biol Blood Marrow Transplant 2014 Oct;20(10):1566-72 PMID: 24972249 PMCID: PMC4169902 SCOPUS ID: 2-s2.0-84912532203 06/28/2014       14 Citations
  • Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. (Jacobsen PB, Le-Rademacher J, Jim H, Syrjala K, Wingard JR, Logan B, Wu J, Majhail NS, Wood W, Rizzo JD, Geller NL, Kitko C, Faber E, Abidi MH, Slater S, Horowitz MM, Lee SJ) Biol Blood Marrow Transplant 2014 Oct;20(10):1530-6 PMID: 24910380 PMCID: PMC4163109 SCOPUS ID: 2-s2.0-84912532936 06/10/2014       67 Citations
  • Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. (Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC, Resource for Clinical Investigation in Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2014 Aug;20(8):1183-9 PMID: 24769014 PMCID: PMC5036168 SCOPUS ID: 2-s2.0-84904068423 04/29/2014       81 Citations
  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation. (Armand P, Kim HT, Logan BR, Wang Z, Alyea EP, Kalaycio ME, Maziarz RT, Antin JH, Soiffer RJ, Weisdorf DJ, Rizzo JD, Horowitz MM, Saber W) Blood 2014 Jun 05;123(23):3664-71 PMID: 24744269 PMCID: PMC4047501 SCOPUS ID: 2-s2.0-84905902438 04/20/2014       701 Citations
  • Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 PMID: 24735965 PMCID: PMC4047500 SCOPUS ID: 2-s2.0-84902150458 04/17/2014       94 Citations
  • Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol. (Yanik GA, Horowitz MM, Weisdorf DJ, Logan BR, Ho VT, Soiffer RJ, Carter SL, Wu J, Wingard JR, Difronzo NL, Ferrara JL, Giralt S, Madtes DK, Drexler R, White ES, Cooke KR) Biol Blood Marrow Transplant 2014 Jun;20(6):858-64 PMID: 24607553 PMCID: PMC4128626 SCOPUS ID: 2-s2.0-84899920388 03/13/2014       59 Citations
  • Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. (Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ) J Allergy Clin Immunol 2014 Apr;133(4):1092-8 PMID: 24290292 PMCID: PMC3972266 SCOPUS ID: 2-s2.0-84897417058 12/03/2013       253 Citations
  • Biobehavioral measures as outcomes: a cautionary tale. (Kovach CR, Woods DL, Devine EC, Logan BR, Raff H) Res Gerontol Nurs 2014;7(2):56-65 PMID: 24158972 PMCID: PMC3965632 SCOPUS ID: 2-s2.0-84903787233 10/26/2013       4 Citations
  • Primary Immune Deficiency Treatment Consortium (PIDTC) report. (Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, Ballard B, Bauer SC, Bleesing JJ, Boyle M, Brower A, Buckley RH, van der Burg M, Burroughs LM, Candotti F, Cant AJ, Chatila T, Cunningham-Rundles C, Dinauer MC, Dvorak CC, Filipovich AH, Fleisher TA, Bobby Gaspar H, Gungor T, Haddad E, Hovermale E, Huang F, Hurley A, Hurley M, Iyengar S, Kang EM, Logan BR, Long-Boyle JR, Malech HL, McGhee SA, Modell F, Modell V, Ochs HD, O'Reilly RJ, Parkman R, Rawlings DJ, Routes JM, Shearer WT, Small TN, Smith H, Sullivan KE, Szabolcs P, Thrasher A, Torgerson TR, Veys P, Weinberg K, Zuniga-Pflucker JC, workshop participants) J Allergy Clin Immunol 2014 Feb;133(2):335-47 PMID: 24139498 PMCID: PMC3960312 SCOPUS ID: 2-s2.0-84895059316 10/22/2013       49 Citations
  • The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. (Dvorak CC, Cowan MJ, Logan BR, Notarangelo LD, Griffith LM, Puck JM, Kohn DB, Shearer WT, O'Reilly RJ, Fleisher TA, Pai SY, Hanson IC, Pulsipher MA, Fuleihan R, Filipovich A, Goldman F, Kapoor N, Small T, Smith A, Chan KW, Cuvelier G, Heimall J, Knutsen A, Loechelt B, Moore T, Buckley RH) J Clin Immunol 2013 Oct;33(7):1156-64 PMID: 23818196 PMCID: PMC3784642 SCOPUS ID: 2-s2.0-84885189606 07/03/2013       87 Citations
  • Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ) Biol Blood Marrow Transplant 2013 Jul;19(7):1102-8 PMID: 23632091 PMCID: PMC3691352 SCOPUS ID: 2-s2.0-84879394074 05/02/2013       16 Citations
  • Peripheral-blood versus bone marrow stem cells. (Anasetti C, Logan BR, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2013 Jan 17;368(3):288 PMID: 23323911 SCOPUS ID: 2-s2.0-84872656511 01/18/2013       14 Citations
  • Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. (Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2013 Mar;19(3):481-5 PMID: 23247045 PMCID: PMC3653300 SCOPUS ID: 2-s2.0-84873591805 12/19/2012       5 Citations
  • Effects of spleen status on early outcomes after hematopoietic cell transplantation. (Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT) Bone Marrow Transplant 2013 Jun;48(6):825-31 PMID: 23222382 PMCID: PMC3606905 SCOPUS ID: 2-s2.0-84879072722 12/12/2012       57 Citations
  • Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 PMID: 23109243 PMCID: PMC3538330 SCOPUS ID: 2-s2.0-84872059501 10/31/2012       101 Citations
  • Review of multistate models in hematopoietic cell transplantation studies. (Logan BR) Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S84-7 PMID: 23084957 PMCID: PMC3867133 SCOPUS ID: 2-s2.0-84871909907 10/23/2012       10 Citations
  • Peripheral-blood stem cells versus bone marrow from unrelated donors. (Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL, Blood and Marrow Transplant Clinical Trials Network) N Engl J Med 2012 Oct 18;367(16):1487-96 PMID: 23075175 PMCID: PMC3816375 10/19/2012    
  • Comparison of the effectiveness of two protocols for treating nursing home residents with advanced dementia. (Kovach CR, Simpson MR, Joosse L, Logan BR, Noonan PE, Reynolds SA, Woods DL, Raff H) Res Gerontol Nurs 2012 Oct;5(4):251-63 PMID: 22998656 PMCID: PMC3475742 SCOPUS ID: 2-s2.0-84868137885 09/25/2012       20 Citations
  • The use of group sequential designs with common competing risks tests. (Logan BR, Zhang MJ) Stat Med 2013 Mar 15;32(6):899-913 PMID: 22945865 PMCID: PMC3574186 SCOPUS ID: 2-s2.0-84873995165 09/05/2012       12 Citations
  • A perspective on the selection of unrelated donors and cord blood units for transplantation. (Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK, National Marrow Donor Program, Center for International Blood and Marrow Transplant Research) Blood 2012 Jul 12;120(2):259-65 PMID: 22596257 PMCID: PMC3398760 SCOPUS ID: 2-s2.0-84864144424 05/19/2012       125 Citations
  • Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID: 22406037 PMCID: PMC3890239 SCOPUS ID: 2-s2.0-84864005064 03/13/2012       50 Citations
  • Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study. (Levine JE, Logan BR, Wu J, Alousi AM, Bolaños-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S) Blood 2012 Apr 19;119(16):3854-60 PMID: 22383800 PMCID: PMC3335389 SCOPUS ID: 2-s2.0-84860345135 03/03/2012       144 Citations
  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID: 22343376 PMCID: PMC3618440 SCOPUS ID: 2-s2.0-84864005843 02/22/2012       164 Citations
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. (Krishnan A, Pasquini MC, Logan B, Stadtmauer EA, Vesole DH, Alyea E 3rd, Antin JH, Comenzo R, Goodman S, Hari P, Laport G, Qazilbash MH, Rowley S, Sahebi F, Somlo G, Vogl DT, Weisdorf D, Ewell M, Wu J, Geller NL, Horowitz MM, Giralt S, Maloney DG, Blood Marrow Transplant Clinical Trials Network (BMT CTN)) Lancet Oncol 2011 Dec;12(13):1195-203 PMID: 21962393 PMCID: PMC3611089 SCOPUS ID: 2-s2.0-82555179157 10/04/2011       248 Citations
  • Failure to identify behavioral symptoms of people with dementia and the need for follow-up physical assessment. (Kovach CR, Logan BR, Joosse LL, Noonan PE) Res Gerontol Nurs 2012 Apr;5(2):89-93 PMID: 21598865 PMCID: PMC3161167 SCOPUS ID: 2-s2.0-84861792107 05/24/2011       7 Citations
  • Diurnal variation of cortisol in people with dementia: relationship to cognition and illness burden. (Kovach CR, Woods DL, Logan BR, Raff H) Am J Alzheimers Dis Other Demen 2011 Mar;26(2):145-50 PMID: 21273205 PMCID: PMC3060946 SCOPUS ID: 2-s2.0-79956053374 01/29/2011       14 Citations
  • Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? (Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, Bredeson CN, Carabasi MH, Gupta V, Hale GA, Khoury HJ, Juckett MB, Litzow MR, Martino R, McCarthy PL, Smith FO, Rizzo JD, Pasquini MC) J Clin Oncol 2011 Mar 01;29(7):805-13 PMID: 21220593 PMCID: PMC3068057 SCOPUS ID: 2-s2.0-79952356420 01/12/2011       162 Citations
  • HLA-matched sibling bone marrow transplantation for β-thalassemia major. (Sabloff M, Chandy M, Wang Z, Logan BR, Ghavamzadeh A, Li CK, Irfan SM, Bredeson CN, Cowan MJ, Gale RP, Hale GA, Horan J, Hongeng S, Eapen M, Walters MC) Blood 2011 Feb 03;117(5):1745-50 PMID: 21119108 PMCID: PMC3056598 SCOPUS ID: 2-s2.0-79551639277 12/02/2010       104 Citations
  • Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. (Barker CC, Agovi MA, Logan B, Lazarus HM, Ballen KK, Gupta V, Hale GA, Frangoul H, Ho V, Rizzo JD, Pasquini MC, Regimen-Related Toxicity Writing Committee, Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2011 May;17(5):737-44 PMID: 20817111 PMCID: PMC3035737 SCOPUS ID: 2-s2.0-79954570682 09/08/2010       25 Citations
  • Graft-versus-host disease treatment: predictors of survival. (Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2010 Dec;16(12):1693-9 PMID: 20541024 PMCID: PMC2955996 SCOPUS ID: 2-s2.0-78149414023 06/15/2010       86 Citations
  • Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. (Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ) Blood 2010 Sep 16;116(11):1839-48 PMID: 20538804 PMCID: PMC3173984 SCOPUS ID: 2-s2.0-77956931642 06/12/2010       161 Citations
  • Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. (Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD) Biol Blood Marrow Transplant 2010 Oct;16(10):1442-50 PMID: 20412867 PMCID: PMC2933950 SCOPUS ID: 2-s2.0-77956270036 04/24/2010       63 Citations
  • Marginal models for clustered time-to-event data with competing risks using pseudovalues. (Logan BR, Zhang MJ, Klein JP) Biometrics 2011 Mar;67(1):1-7 PMID: 20377579 PMCID: PMC2902638 SCOPUS ID: 2-s2.0-79952586078 04/10/2010       34 Citations
  • Factors associated with time to identify physical problems of nursing home residents with dementia. (Kovach CR, Logan BR, Simpson MR, Reynolds S) Am J Alzheimers Dis Other Demen 2010 Jun;25(4):317-23 PMID: 20237337 PMCID: PMC2884077 SCOPUS ID: 2-s2.0-77953631532 03/20/2010       24 Citations
  • Second unrelated donor hematopoietic cell transplantation for primary graft failure. (Schriber J, Agovi MA, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC) Biol Blood Marrow Transplant 2010 Aug;16(8):1099-106 PMID: 20172038 PMCID: PMC2897953 SCOPUS ID: 2-s2.0-77954316434 02/23/2010       69 Citations
  • Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. (Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D) Biol Blood Marrow Transplant 2010 Mar;16(3):421-9 PMID: 19925875 PMCID: PMC3104501 SCOPUS ID: 2-s2.0-75749125789 11/21/2009       31 Citations
  • The effect of smoking on allogeneic transplant outcomes. (Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringdén O, Schouten HC, Seftel M, Rizzo JD) Biol Blood Marrow Transplant 2009 Oct;15(10):1277-87 PMID: 19747636 PMCID: PMC2768519 SCOPUS ID: 2-s2.0-69749091932 09/15/2009       23 Citations
  • Prognostic impact of C-REL expression in diffuse large B-cell lymphoma. (Curry CV, Ewton AA, Olsen RJ, Logan BR, Preti HA, Liu YC, Perkins SL, Chang CC) J Hematop 2009 Mar;2(1):20-6 PMID: 19669219 PMCID: PMC2713494 SCOPUS ID: 2-s2.0-79551526994 08/12/2009       21 Citations
  • Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. (Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL) Blood 2009 Sep 24;114(13):2606-16 PMID: 19608747 PMCID: PMC2756121 SCOPUS ID: 2-s2.0-70350513277 07/18/2009       117 Citations
  • Prior rituximab correlated with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation (PBSCT). (Ratanatarathorn, V., Logan, B., Wang, D., Horowitz, M., Uberti, J.P., Ringden, O., Gale, R.P., Khoury, H., Arora, M., Spellman, S., Cutler, C., Antin, J., Bornhauser, M., Hale, G., Verdonck, L., Cairo, M., Gupta, V., Pavletic, S. ) British Journal of Hematology 145: 816-824 06/02/2009    
  • Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. (Alousi AM, Weisdorf DJ, Logan BR, Bolaños-Meade J, Carter S, Difronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE, Blood and Marrow Transplant Clinical Trials Network) Blood 2009 Jul 16;114(3):511-7 PMID: 19443659 PMCID: PMC2713466 SCOPUS ID: 2-s2.0-70149109879 05/16/2009       187 Citations
  • Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. (van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN) Biol Blood Marrow Transplant 2009 May;15(5):554-63 PMID: 19361747 PMCID: PMC3120935 SCOPUS ID: 2-s2.0-63749130619 04/14/2009       28 Citations
  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL) Blood 2009 Apr 09;113(15):3604-11 PMID: 19190248 PMCID: PMC2668845 SCOPUS ID: 2-s2.0-65349145905 02/05/2009       212 Citations
  • Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM) Bone Marrow Transplant 2009 Mar;43(6):435-46 PMID: 19182830 SCOPUS ID: 2-s2.0-63949083153 02/03/2009       25 Citations
  • Methods for equivalence and noninferiority testing. (Tunes da Silva G, Logan BR, Klein JP) Biol Blood Marrow Transplant 2009 Jan;15(1 Suppl):120-7 PMID: 19147090 PMCID: PMC2701110 SCOPUS ID: 2-s2.0-64749104971 01/29/2009       96 Citations
  • Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. (Devetten MP, Hari PN, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P) Biol Blood Marrow Transplant 2009 Jan;15(1):109-17 PMID: 19135949 PMCID: PMC2929570 SCOPUS ID: 2-s2.0-58149197557 01/13/2009       91 Citations
  • Use of biological assignment in hematopoietic stem cell transplantation clinical trials. (Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N) Clin Trials 2008;5(6):607-16 PMID: 19029209 PMCID: PMC2671015 SCOPUS ID: 2-s2.0-61449562164 11/26/2008       20 Citations
  • Superiority inferences on individual endpoints following noninferiority testing in clinical trials. (Logan BR, Tamhane AC) Biom J 2008 Oct;50(5):693-703 PMID: 18932132 SCOPUS ID: 2-s2.0-54549125945 10/22/2008       13 Citations
  • Analyzing center specific outcomes in hematopoietic cell transplantation. (Logan BR, Nelson GO, Klein JP) Lifetime Data Anal 2008 Dec;14(4):389-404 PMID: 18836830 PMCID: PMC2709496 SCOPUS ID: 2-s2.0-55949120408 10/07/2008       16 Citations
  • Inference for current leukemia free survival. (Liu L, Logan B, Klein JP) Lifetime Data Anal 2008 Dec;14(4):432-46 PMID: 18663574 PMCID: PMC2715962 SCOPUS ID: 2-s2.0-55949114901 07/30/2008       13 Citations
  • Behavior modification and risk perception in patients with nonmelanoma skin cancer. (Rhee JS, Davis-Malesevich M, Logan BR, Neuburg M, Burzynski M, Nattinger AB) WMJ 2008 Apr;107(2):62-8 PMID: 18593080 PMCID: PMC3590063 SCOPUS ID: 2-s2.0-42149137951 07/03/2008       24 Citations
  • On the probability of using cord blood. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Jun;14(6):724-5 PMID: 18489999 SCOPUS ID: 2-s2.0-43649090840 05/21/2008       4 Citations
  • Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. (Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM) Med Decis Making 2008;28(2):243-53 PMID: 18349441 SCOPUS ID: 2-s2.0-41149179076 03/20/2008       34 Citations
  • Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. (Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM) Biol Blood Marrow Transplant 2008 Mar;14(3):316-22 PMID: 18275898 PMCID: PMC2531159 SCOPUS ID: 2-s2.0-38949210240 02/16/2008       50 Citations
  • Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. (Logan BR, Klein JP, Zhang MJ) Biometrics 2008 Sep;64(3):733-740 PMID: 18190619 PMCID: PMC2754119 SCOPUS ID: 2-s2.0-49749103124 01/15/2008       54 Citations
  • State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. (Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program) Biol Blood Marrow Transplant 2008 Jan;14(1):1-6 PMID: 18158954 SCOPUS ID: 2-s2.0-37349091178 12/27/2007       69 Citations
  • Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. (Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ) Bone Marrow Transplant 2008 Apr;41(7):635-42 PMID: 18084335 PMCID: PMC2587442 SCOPUS ID: 2-s2.0-42149177725 12/18/2007       46 Citations
  • An evaluation of spatial thresholding techniques in fMRI analysis. (Logan BR, Geliazkova MP, Rowe DB) Hum Brain Mapp 2008 Dec;29(12):1379-89 PMID: 18064589 PMCID: PMC6870886 SCOPUS ID: 2-s2.0-57149096884 12/08/2007       25 Citations
  • Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. (Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C) Biol Blood Marrow Transplant 2007 Dec;13(12):1461-8 PMID: 18022576 PMCID: PMC2267869 SCOPUS ID: 2-s2.0-36048969811 11/21/2007       157 Citations
  • Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis. (Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD) Biol Blood Marrow Transplant 2007 Jul;13(7):778-89 PMID: 17580256 SCOPUS ID: 2-s2.0-34250208443 06/21/2007       10 Citations
  • Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. (Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D) Biol Blood Marrow Transplant 2007 Jul;13(7):844-52 PMID: 17580263 SCOPUS ID: 2-s2.0-34250192560 06/21/2007       63 Citations
  • Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. (Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ) Blood 2007 Jul 01;110(1):409-17 PMID: 17374741 PMCID: PMC1896123 SCOPUS ID: 2-s2.0-34347391058 03/22/2007       67 Citations
  • Analyzing survival curves at a fixed point in time. (Klein JP, Logan B, Harhoff M, Andersen PK) Stat Med 2007 Oct 30;26(24):4505-19 PMID: 17348080 SCOPUS ID: 2-s2.0-35148838428 03/10/2007       256 Citations
  • Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment. (Gorski J, Chen X, Gendelman M, Yassai M, Krueger A, Tivol E, Logan B, Komorowski R, Vodanovic-Jankovic S, Drobyski WR) Blood 2007 Jun 15;109(12):5502-10 PMID: 17347406 PMCID: PMC1890817 SCOPUS ID: 2-s2.0-34249979259 03/10/2007       16 Citations
  • The skin cancer index: clinical responsiveness and predictors of quality of life. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Laryngoscope 2007 Mar;117(3):399-405 PMID: 17334300 PMCID: PMC1847346 SCOPUS ID: 2-s2.0-33947187783 03/06/2007       109 Citations
  • Effects of gadolinium on regionally stunned myocardium: temporal considerations. (Nicolosi AC, Kwok CS, Logan B) J Surg Res 2007 May 15;139(2):286-91 PMID: 17270216 SCOPUS ID: 2-s2.0-34047263271 02/03/2007       4 Citations
  • Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer. (Rhee JS, Matthews BA, Neuburg M, Logan BR, Burzynski M, Nattinger AB) Arch Facial Plast Surg 2006;8(5):314-8 PMID: 16982987 PMCID: PMC2556600 SCOPUS ID: 2-s2.0-33749319238 09/20/2006       92 Citations
  • Effects of the Serial Trial Intervention on discomfort and behavior of nursing home residents with dementia. (Kovach CR, Logan BR, Noonan PE, Schlidt AM, Smerz J, Simpson M, Wells T) Am J Alzheimers Dis Other Demen 2006;21(3):147-55 PMID: 16869334 PMCID: PMC10833286 SCOPUS ID: 2-s2.0-33745906237 07/28/2006       119 Citations
  • Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. (Logan BR, Zhang MJ, Klein JP) Biol Blood Marrow Transplant 2006 Jan;12(1 Suppl 1):107-12 PMID: 16399594 SCOPUS ID: 2-s2.0-29844457717 01/10/2006       37 Citations
  • Optimal two-stage randomized phase II clinical trials. (Logan BR) Clin Trials 2005;2(1):5-12 PMID: 16279574 SCOPUS ID: 2-s2.0-14744305954 11/11/2005       7 Citations
  • Reliability of biomechanical spasticity measurements at the elbow of people poststroke. (Starsky AJ, Sangani SG, McGuire JR, Logan B, Schmit BD) Arch Phys Med Rehabil 2005 Aug;86(8):1648-54 PMID: 16084821 SCOPUS ID: 2-s2.0-23644447247 08/09/2005       65 Citations
  • Pairwise multiple comparison adjustment in survival analysis. (Logan BR, Wang H, Zhang MJ) Stat Med 2005 Aug 30;24(16):2509-23 PMID: 15977296 SCOPUS ID: 2-s2.0-23244466624 06/25/2005       20 Citations
  • Clinical risk factors associated with bleeding after native kidney biopsy. (Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, Piering WF) Nephrology (Carlton) 2005 Jun;10(3):305-10 PMID: 15958047 SCOPUS ID: 2-s2.0-21344458186 06/17/2005       109 Citations
  • The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. (McGregor DK, Keever-Taylor CA, Bredeson C, Schur B, Vesole DH, Logan B, Chang CC) Bone Marrow Transplant 2005 Jun;35(11):1049-54 PMID: 15821762 SCOPUS ID: 2-s2.0-20044389355 04/12/2005       5 Citations
  • Complex fMRI analysis with unrestricted phase is equivalent to a magnitude-only model. (Rowe DB, Logan BR) Neuroimage 2005 Jan 15;24(2):603-6 PMID: 15627605 SCOPUS ID: 2-s2.0-16244374284 01/04/2005       32 Citations
  • Finding the maximum safe dose level for heteroscedastic data. (Tamhane AC, Logan BR) J Biopharm Stat 2004 Nov;14(4):843-56 PMID: 15587967 SCOPUS ID: 2-s2.0-9244227065 12/14/2004       16 Citations
  • A complex way to compute fMRI activation. (Rowe DB, Logan BR) Neuroimage 2004 Nov;23(3):1078-92 PMID: 15528108 SCOPUS ID: 2-s2.0-7444224673 11/06/2004       79 Citations
  • Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity? (Hari P, Logan B, Drobyski WR) Biol Blood Marrow Transplant 2004 Nov;10(11):743-7 PMID: 15505605 SCOPUS ID: 2-s2.0-6444236370 10/27/2004       9 Citations
  • Routine screening for psychosocial distress following hematopoietic stem cell transplantation. (Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP, Cutler C, Ho VT, Richardson PG, Schlossman RL, Fisher DC, Logan B, Soiffer RJ) Bone Marrow Transplant 2005 Jan;35(1):77-83 PMID: 15502851 SCOPUS ID: 2-s2.0-19944429515 10/27/2004       112 Citations
  • A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials. (Tamhane, A.C. and Logan, B.R. ) Biometrika 91: 715-727 09/01/2004    
  • Alpha phenyl-tert-butyl nitrone (PBN) protects syngeneic marrow transplant recipients from the lethal cytokine syndrome occurring after agonistic CD40 antibody administration. (Gendelman M, Halligan N, Komorowski R, Logan B, Murphy WJ, Blazar BR, Pritchard KA Jr, Drobyski WR) Blood 2005 Jan 01;105(1):428-31 PMID: 15331451 SCOPUS ID: 2-s2.0-11144225851 08/28/2004       10 Citations
  • An evaluation of thresholding techniques in fMRI analysis. (Logan BR, Rowe DB) Neuroimage 2004 May;22(1):95-108 PMID: 15110000 SCOPUS ID: 2-s2.0-1942425117 04/28/2004       99 Citations
  • Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. (Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL) Am J Surg Pathol 2004 Apr;28(4):464-70 PMID: 15087665 SCOPUS ID: 2-s2.0-1842529746 04/17/2004       230 Citations
  • Reproducibility of spinal back-contour measurements taken with raster stereography in adolescent idiopathic scoliosis. (Lyon R, Liu XC, Thometz JG, Nelson ER, Logan B) Am J Orthop (Belle Mead NJ) 2004 Feb;33(2):67-70 PMID: 15005595 SCOPUS ID: 2-s2.0-2542424857 03/10/2004       13 Citations
  • Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. (Gendelman, M., Hecht, T., Logan, B., Vodanovic-Jankovic, S., Komorowski, R., and Drobyski, W.R. ) Journal of Immunology 172: 3328 – 3336 03/01/2004    
  • On O’Brien’s OLS and GLS tests for multiple endpoints. (Logan, B.R. and Tamhane, A.C. ) Recent Developments in Multiple Comparison Procedures, IMS Lecture Notes - Monograph Series 47:76-88 01/01/2004    
  • National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. (Hurley CK, Baxter Lowe LA, Logan B, Karanes C, Anasetti C, Weisdorf D, Confer DL) Biol Blood Marrow Transplant 2003 Oct;9(10):610-5 PMID: 14569557 SCOPUS ID: 2-s2.0-1542338334 10/22/2003       75 Citations
  • Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. (Chang CC, Bredeson C, Juckett M, Logan B, Keever-Taylor CA) Bone Marrow Transplant 2003 Aug;32(3):287-91 PMID: 12858200 SCOPUS ID: 2-s2.0-0043171049 07/15/2003       14 Citations
  • Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. (Chang CC, Kampalath B, Schultz C, Bunyi-Teopengco E, Logan B, Eshoa C, Dincer AP, Perkins SL) Arch Pathol Lab Med 2003 Feb;127(2):208-12 PMID: 12562237 SCOPUS ID: 2-s2.0-0037329971 02/04/2003       71 Citations
  • A cone order monotone test for the one-sided multivariate testing problem. (Logan, B.R.) Statistics and Probability Letters 63: 315-323 01/01/2003    
  • Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. (Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B, Kampalath B, Cleveland RP) Blood 2002 Dec 15;100(13):4671-5 PMID: 12393648 SCOPUS ID: 2-s2.0-0037114759 10/24/2002       53 Citations
  • Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. (Tamhane AC, Logan BR) Biometrics 2002 Sep;58(3):650-6 PMID: 12230000 SCOPUS ID: 2-s2.0-0036714878 09/17/2002       13 Citations
  • Role of the passive apoptotic pathway in graft-versus-host disease. (Drobyski, W.R., Komorowski, R., Logan, B., Gendelman, M.) Journal of Immunology 169: 1626-1633 08/01/2002    
  • Gadolinium attenuates regional stunning in the canine heart in vivo. (Nicolosi AC, West G, Markley JG, Logan B, Olinger GN) J Thorac Cardiovasc Surg 2002 Jul;124(1):57-62 PMID: 12091809 SCOPUS ID: 2-s2.0-0036657511 07/02/2002       8 Citations
  • Multiple test procedures for identifying the minimum effective and maximum safe doses of a drug. (Tamhane, A.C. and Logan, B.R.) Journal of the American Statistical Association 97: 293-301 01/01/2002    
  • Combining global and marginal tests to compare two treatments on multiple endpoints. (Logan, B.R. and Tamhane, A.C.) Biometrical Journal 43: 591-604 08/28/2001    
    • Last update: 04/30/2024